Prakt. lékáren. 2014; 10(1): 26-29
Inflammatory bowel diseases are chronic inflammatory processes, primarily affecting the intestinal mucosa. The chronic course of the disease
is characterized by periods of remission alternating with acute flare-ups of the disease. Inflammatory bowel diseases are conditions with an
increasing severity given their growing incidence, chronic nature, difficult therapeutic management, and predominance in the highly productive
age. Preparations of 5-aminosalicylic acid (5-ASA), corticosteroids, immunosuppressants, and antibiotics remain the mainstay of conservative
treatment: The goal of the treatment is remission induction, its maintenance, and improvement in the quality of life of the patient. The paper aims
to summarize the existing therapeutic options and discuss administration of pharmaceutical care in patients with inflammatory bowel disease.
Published: February 10, 2014 Show citation